Skip to content

Insider · CIK 0001364719

Michael Kauffman

director

Files at KYNB (FIBROGEN INC), VSTM (Verastem, Inc.), KZR (Kezar Life Sciences, Inc.). First filing Nov 25, 2025, latest Nov 25, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $86k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

VSTM: Verastem, Inc.

VSTMOct 9, 2026 · close 8.38

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
29Weak
VSTMsell 310b5-1
Verastem, Inc.
$86k
8,550 shares
-50%+172% from low-7% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 21, 2025VSTM
Verastem, Inc.
SOpen-market sale
Common Stock10b5-1
-8,550$10.00$86k8,666Nov 25, 2025
Jun 18, 2025KZR
Kezar Life Sciences, Inc.
AGrant or award
Stock Option (right to buy)derivative
+5,000$0.00$05,000Jun 23, 2025
Jun 4, 2025KYNB
FIBROGEN INC
AGrant or award
Stock Option (Right to Buy)derivative
+70,000$0.00$070,000Jun 6, 2025
Jun 4, 2025KYNB
FIBROGEN INC
AGrant or award
Stock Option (Right to Buy)derivative
+120,000$0.00$0120,000Jun 6, 2025
May 22, 2025VSTM
Verastem, Inc.
AGrant or award
Common Stock
+8,333$0.00$017,216May 27, 2025
May 22, 2025VSTM
Verastem, Inc.
AGrant or award
Stock Option (right to buy)derivative
+12,500$0.00$012,500May 27, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michael Kauffman: insider trades and track record | InsiderTell